These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9795420)

  • 1. [Inhibition of thrombocyte aggregation. Current trends in the treatment of acute coronary syndromes].
    Z Kardiol; 1998 Sep; 87(9 Suppl):1-4. PubMed ID: 9795420
    [No Abstract]   [Full Text] [Related]  

  • 2. [The pharmacological treatment of acute coronary syndromes].
    Moreno Gómez R; López-Sendón Hentschel JL; López de Sá Areses E; Rubio Sanz R; Pérez Castellano N; Delcán Domínguez JL
    Rev Clin Esp; 1996 Dec; 196(4 Monografico):13-25. PubMed ID: 9139328
    [No Abstract]   [Full Text] [Related]  

  • 3. Is fibrinolysis critical for acute coronary syndromes?
    Kluft C; Andreotti F
    Ital Heart J; 2001 Sep; 2(9):639-40. PubMed ID: 11666088
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute coronary syndromes: new developments in pharmacological treatment strategies.
    Gylys K; Gold M
    Crit Care Nurse; 2000 Apr; Suppl():3-14; quiz 15-6. PubMed ID: 11876169
    [No Abstract]   [Full Text] [Related]  

  • 5. [The treatment of acute coronary syndromes of the "non-ST elevation" type with enoxaparin: the TIMI 11B study. Thrombolysis in Myocardial Infarct].
    Galli M
    Ital Heart J Suppl; 2000 Apr; 1(4):575-6. PubMed ID: 10832148
    [No Abstract]   [Full Text] [Related]  

  • 6. Stabilizing unstable plaque in acute coronary syndromes: implications for cardiac surgical patients.
    Weber MM; McErlean ES
    Crit Care Nurse; 2000 Aug; 20(4):78-91. PubMed ID: 11876339
    [No Abstract]   [Full Text] [Related]  

  • 7. [Non-fractionated heparin versus low molecular weight heparin in acute coronary syndromes].
    González Pacheco H
    Arch Cardiol Mex; 2001; 71 Suppl 1():S63-8. PubMed ID: 11565348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation in atherosclerosis: some thoughts about acute coronary syndromes.
    Lucas AR; Korol R; Pepine CJ
    Circulation; 2006 May; 113(17):e728-32. PubMed ID: 16651475
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antithrombotic treatment of acute coronary syndromes].
    Patrono C; Malliani A
    Recenti Prog Med; 2001 Nov; 92(11 Suppl):3A-7A. PubMed ID: 11822106
    [No Abstract]   [Full Text] [Related]  

  • 10. The mechanisms of the anticoagulant and antithrombotic medications used in the treatment of acute coronary syndrome (ACS).
    Albritton S; Shuler L; Schatz K
    Crit Care Nurse; 2001 Aug; 21(4):75-7. PubMed ID: 11858692
    [No Abstract]   [Full Text] [Related]  

  • 11. [Medical treatment of acute coronary syndrome without ST-segment elevation].
    Collet JP; Choussat R; Montalescot G
    Rev Prat; 2003 Mar; 53(6):624-8. PubMed ID: 12749148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of thrombocytes and thrombocyte aggregation inhibitors in coronary disease].
    Schlimmer P
    ZFA (Stuttgart); 1980 Sep; 56(26):1621-4. PubMed ID: 7456654
    [No Abstract]   [Full Text] [Related]  

  • 13. Restoration of flow in acute coronary obstructive syndromes.
    Naylor CD
    Can J Cardiol; 1989 Sep; 5(6):VII. PubMed ID: 2790572
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of acute coronary syndromes: have we reached the ceiling?
    Wallentin L
    Nat Clin Pract Cardiovasc Med; 2005 Apr; 2(4):173. PubMed ID: 16265463
    [No Abstract]   [Full Text] [Related]  

  • 15. [Platelet activation in acute coronary syndrome and interventional therapy].
    Bigalke B; Lindemann S; Gawaz M
    Hamostaseologie; 2007 Dec; 27(5):338-43. PubMed ID: 18060243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bleeding complications after treatment with antithrombotic agents after acute coronary syndrome].
    Kristensen SD
    Ugeskr Laeger; 2006 Sep; 168(38):3201. PubMed ID: 17026890
    [No Abstract]   [Full Text] [Related]  

  • 17. Severity of chronic kidney disease did not influence bleeding during treatment of acute coronary syndromes.
    Lee A; Lum JJ; Seto TB; Spies C; Madison JR
    Hawaii Med J; 2004 Nov; 63(11):333-6. PubMed ID: 15633659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-molecular-weight heparins and glycoprotein IIb/IIIa inhibitors with percutaneous coronary intervention in acute coronary syndromes.
    Shimpi RA
    J Invasive Cardiol; 2003 Aug; 15(8):460-5. PubMed ID: 12890880
    [No Abstract]   [Full Text] [Related]  

  • 19. [Is early invasive treatment in acute coronary syndromes necessary? Suggestions to alternative interpretation of the FRISC II study].
    Möller BH
    Lakartidningen; 2002 Aug; 99(32-33):3219-24. PubMed ID: 12219478
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of non-thrombolysable acute coronary syndrome (ACS).
    Iyengar S; Myint PK; Grabau W
    Hosp Med; 2005 Jul; 66(7):434. PubMed ID: 16025809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.